VP3: Vancouver primary prevention project (anxiety disorders prevention in school children)

ISRCTN ISRCTN72046738
DOI https://doi.org/10.1186/ISRCTN72046738
ClinicalTrials.gov number NCT00247754
Secondary identifying numbers MCT-53658
Submission date
24/02/2006
Registration date
24/02/2006
Last edited
07/01/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Lynn Miller
Scientific

University of British Columbia
Faculty of Education
2125 Main Mall
Vancouver
V6T 1Z4
Canada

Phone +1 604 822 8539
Email lynn.miller@ubc.ca

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific titleVP3: Vancouver primary prevention project (anxiety disorders prevention in school children)
Study acronymVP3
Study objectives1. A cognitive behavior therapy (CBT) oriented intervention as delivered by school personnel will be superior to an attention control procedure in reducing anxiety symptoms in at-risk children
2. Children who have parental involvement will post stronger and more enduring treatment gains
Ethics approval(s)Behavioural Research Ethics Board, University of British Columbia, Vancouver, British Columbia, Canada (12 November, 2004).
Health condition(s) or problem(s) studiedAnxiety disorders
InterventionCognitive behavior therapy (CBT) or an attention control procedure (storytelling)

Trial details received: 12 Sept 2005
Intervention typeOther
Primary outcome measureAnxiety symptoms
Secondary outcome measures1. Extension to other school systems within BC (outside Vancouver)
2. Modification of protocol to minority populations/foreign language
3. Upward and downward modification (age range) of protocol
Overall study start date01/04/2002
Completion date30/06/2005

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit5 Years
Upper age limit11 Years
SexBoth
Target number of participants281
Total final enrolment1039
Key inclusion criteria1. Anxiety disorder symptoms (identified by a score of 56 or higher on the Multidimensional Anxiety Scale for Children [MASC]; and teacher report, and/or parent recommendation) as the primary presenting problem
2. Aged 5 - 11 years old, either sex
3. An enrolled child must have at least 2 of these criteria:
a. Fluency in English
b. Parent willingness to sign consent form and to complete required assessments
c. Student willingness to participate (child assent) in 10-week affective education program and completion of required assessments
Key exclusion criteria1. Any condition which prevents the subject from participating in 10 consecutive weeks of involvement in the group
2. Special education services provided (e.g. substantial learning disabled, enrollment in other special needs program or receiving private therapeutic services)
3. Organic mental disorder or mental retardation
4. Commencement of psychotropic medication within the past 3 months. Currently medicated children will be accepted in to the study providing they (and their treating physicians) agree to keep their doses constant throughout the course of the study.
Date of first enrolment01/04/2002
Date of final enrolment30/06/2005

Locations

Countries of recruitment

  • Canada

Study participating centre

University of British Columbia
Vancouver
V6T 1Z4
Canada

Sponsor information

University of British Columbia (Canada)
Not defined

2075 Wesbrook Mall
Vancouver
V6T 1Z1
Canada

ROR logo "ROR" https://ror.org/03rmrcq20

Funders

Funder type

Research organisation

Canadian Institutes of Health Research (CIHR) (Canada) - http://www.cihr-irsc.gc.ca (ref: MCT-53658)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/01/2014 07/01/2021 Yes No

Editorial Notes

07/01/2021: The following changes have been made:
1. Publication reference added.
2. The total final enrolment number has been added from the reference.
28/01/2019: No publications found, verifying results with the principal investigator